(Phys.org) -- An undergraduate student's technique for detecting certain metabolites in urine samples could lead to a simpler and more accurate way to test for prostate cancer.
Jul 24, 2012
2 / 5 (1)
0
The research teams headed by Prof. Johanna Ivaska (University of Turku and VTT Technical Research Centre of Finland) and Prof. Marko Salmi (University of Turku and the National Institute for Health and Welfare) have discovered ...
Nov 16, 2011
4 / 5 (1)
0
The widely known PSA blood test for prostate cancer in men may get a second life as a much-needed new test for breast cancer, the most common form of cancer in women worldwide, scientists are reporting in a new study in the ...
Jul 13, 2011
2 / 5 (1)
0
Screening does not significantly reduce prostate cancer deaths, but the risk of overdetection and overtreatment is considerable, concludes a 20-year study published in the British Medical Journal today.
Apr 01, 2011
5 / 5 (2)
1
A new study on the use of prostate-specific antigen (PSA)-based prostate cancer screening in the United States found that many elderly men may be undergoing unnecessary prostate cancer screenings. Using data from surveys ...
Mar 28, 2011
5 / 5 (1)
0
In the February 2011 issue of European Urology, Jean-Nicolas Cornu and colleagues reported the evaluation of the efficacy of prostate cancer (PCa) detection by trained dogs on human urine samples.
Feb 07, 2011
5 / 5 (1)
0
In July 2010, a research team led by Jonas Hugosson, professor in urology at the Sahlgrenska Academy, presented the results of a large randomised study of screening for prostate cancer in Gothenburg, with a 14-year follow ...
Jan 11, 2011
4 / 5 (2)
0
Scientists from deCODE genetics and academic colleagues from Iceland, the UK, US, Netherlands, Spain and Romania today report the discovery of a set of single-letter variations in the sequence of the human genome (SNPs) that ...
Dec 15, 2010
5 / 5 (2)
0
Researchers at the National Institutes of Health have found that variations in a gene for an enzyme involved in cell energy metabolism appear to increase the risk for prostate cancer.
Oct 01, 2010
5 / 5 (3)
0
Existing evidence from randomised controlled trials does not support routine population screening for prostate cancer, concludes a study published in the British Medical Journal today.
Sep 15, 2010
not rated yet
0
Men aged 55 to 74 years who have low baseline blood levels of prostate specific antigen (PSA) are not likely to benefit from further screening and treatment. That is the conclusion of a new study published early online in ...
Sep 13, 2010
5 / 5 (2)
0
Prostate cancer is a significant public health concern and cause of morbidity among American men. It is the most commonly diagnosed cancer in the United States (excluding skin cancers) and is second only to lung cancer as ...
Sep 01, 2010
1 / 5 (1)
0
In Germany, several national health campaigns promote cancer screening by announcing that only one in five German men gets screened. This is supposed to motivate men to have an examination. But a new study published in Psychological Sc ...
Jul 27, 2010
not rated yet
0
Men who have a baseline PSA value of 10 or higher the first time they are tested are up to 11 times more likely to die from prostate cancer than are men with lower initial values, according to Duke University Medical Center ...
Jul 08, 2010
5 / 5 (1)
0
or clues such as pre-cancerous cells - is strongly encouraged as a way of improving public health. However, there are doubts as to whether the benefits of screening outweighs the negatives. Over-diagnosis is one of the biggest ...
Jun 30, 2010
4 / 5 (5)
0
